Champaign, IL, United States of America

Charles Abbas

This inventor holds 23 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 9 EPO patents. Top assignees: Archer Daniels Midland Company, Battelle Memorial Institute. Active years: 2006-2024.

USPTO Granted Patents = 23 

% Patents Active = 95.7


 

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 223(Granted Patents)


Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: The Innovative Journey of Charles Abbas

Introduction: Charles Abbas, a visionary inventor based in Champaign, IL, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Charles Abbas holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Charles Abbas has worked with leading research institutions and technology companies to bring his inventions to life. His commitment to pushing the boundaries of innovation has led to the development of cutting-edge solutions that have positively impacted various industries.

Collaborations: Throughout his career, Charles Abbas has collaborated with top engineers, scientists, and designers to enhance the functionality and efficiency of his inventions. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Charles Abbas continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of excellence in the field of technology. His contributions have not only transformed industries but have also improved the quality of life for people around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…